Travere Therapeutics, Inc.
USD42.96
-2.08 (-4.62%)
CEO
Eric Dube
IPO Date
2012-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$44.06
Prev. Close
$45.04
Day Low
$42.38
Day High
$44.70
52W Low
$13.88
52W High
$48.61
Market Cap
$3.99B
Volume
2.25M
| 12,000 |
| $42.26 |
| 21 May 2026 | Squarer Ron | director | A-Award | Acquired | 4,000 | $0.00 |
| 21 May 2026 | Squarer Ron | director | A-Award | Acquired | 12,000 | $42.26 |
| 21 May 2026 | Poole Sandra | director | A-Award | Acquired | 4,000 | $0.00 |
| 21 May 2026 | Poole Sandra | director | A-Award | Acquired | 12,000 | $42.26 |
| 21 May 2026 | Orwin John A | director | A-Award | Acquired | 4,000 | $0.00 |
| 21 May 2026 | Orwin John A | director | A-Award | Acquired | 12,000 | $42.26 |
| 21 May 2026 | Meckler Jeffrey A | director | A-Award | Acquired | 4,000 | $0.00 |
| 21 May 2026 | Meckler Jeffrey A | director | A-Award | Acquired | 12,000 | $42.26 |